The store will not work correctly when cookies are disabled.
2-oxo-1-phenyl-N-(2-(thiophen-2-yl)ethyl)pyrrolidine-3-carboxamide
ID: ALA4568227
PubChem CID: 20964219
Max Phase: Preclinical
Molecular Formula: C17H18N2O2S
Molecular Weight: 314.41
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(NCCc1cccs1)C1CCN(c2ccccc2)C1=O
Standard InChI: InChI=1S/C17H18N2O2S/c20-16(18-10-8-14-7-4-12-22-14)15-9-11-19(17(15)21)13-5-2-1-3-6-13/h1-7,12,15H,8-11H2,(H,18,20)
Standard InChI Key: NUHVNPAAEPGUFR-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
10.4609 -10.8414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4597 -11.6687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1745 -12.0816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8909 -11.6683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8880 -10.8377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1727 -10.4286 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1643 -9.6028 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.8303 -9.1158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5730 -8.3320 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7480 -8.3344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4955 -9.1198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6156 -9.3683 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.2831 -7.9123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0016 -8.3175 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.2747 -7.0874 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.7119 -7.8978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4304 -8.3030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4388 -9.1280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7800 -9.6212 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
14.0429 -10.4032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8679 -10.3948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1147 -9.6076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 7 1 0
6 7 1 0
8 12 2 0
9 13 1 0
13 14 1 0
13 15 2 0
14 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 18 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 314.41 | Molecular Weight (Monoisotopic): 314.1089 | AlogP: 2.46 | #Rotatable Bonds: 5 |
Polar Surface Area: 49.41 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 2.38 | CX LogD: 2.38 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.86 | Np Likeness Score: -2.17 |
References
1. Heinrich T, Seenisamy J, Blume B, Bomke J, Calderini M, Eckert U, Friese-Hamim M, Kohl R, Lehmann M, Leuthner B, Musil D, Rohdich F, Zenke FT.. (2019) Discovery and Structure-Based Optimization of Next-Generation Reversible Methionine Aminopeptidase-2 (MetAP-2) Inhibitors., 62 (10): [PMID:30939017] [10.1021/acs.jmedchem.9b00041] |